Kynurenine pathway in kidney diseasesIzabela Zakrocka, Wojciech Załuska|Pharmacological Reports|2021Cited by 53
Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical ApplicationsIzabela Zakrocka, Waldemar A. Turski, Katarzyna M. Targowska‐Duda et al.|Neurotoxicity Research|2017Cited by 36
Matrix metalloproteinases and atherosclerosisPiotr Fic, Andrzej Stepulak, Izabela Zakrocka et al.|Postępy Higieny i Medycyny Doświadczalnej|2011Cited by 34
Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive ratsBożena Bądzyńska, Elżbieta Kompanowska‐Jezierska, Izabela Zakrocka et al.|European Journal of Pharmacology|2014Cited by 26
Kynurenic acid selectively reduces heart rate in spontaneously hypertensive ratsBożena Bądzyńska, Elżbieta Kompanowska‐Jezierska, Izabela Zakrocka et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2019Cited by 18